2024. INVESTIGATING NEURON-SPECIFIC ENOLASE AS A DIAGNOSTIC MARKER FOR EARLY DETECTION OF DIABETIC PERIPHERAL NEUROPATHY IN PATIENTS WITH TYPE II DIABETES MELLITUS. Journal of Population Therapeutics and Clinical Pharmacology. 31, 9 (Sep. 2024), 1095–1105. DOI:https://doi.org/10.53555/jb11kw29.